Clinical Development Lead — Neuro-Oncology & Autoimmunity

Scorpion Therapeutics; United States; Remote; USD 230,000 - 290,000; Full time

Job summary

Scorpion Therapeutics is seeking a Medical Director to provide clinical oversight and monitoring for early to mid-phase oncology and autoimmune trials, with a focus on neurology and autoimmune indications, including CAR T therapies. The role involves study design input, regulatory interactions, and cross-functional collaboration.

Candidates should have an MD/DO with 2-5 years in clinical/scientific drug development, GCP knowledge, and the ability to engage investigators.

Qualifications

• MD or DO with 2–5 years in clinical/scientific/drug development experience.
• Knowledge of GCP, clinical trial design, and safety review.
• Preferred: neurology/neuroimmunology expertise and experience in early-phase studies.

Responsibilities

• Provide clinical oversight for early- to mid-phase oncology and autoimmune trials, focusing on neurology and autoimmune indications (including CAR T therapies).
• Contribute to study design, draft/review clinical documents, support investigator engagement, identify study risks, interpret translational findings, and collaborate across regulatory, safety, clinical operations, and biometrics.
• Engage in regulatory interactions and external stakeholder engagement, with potential for scientific presentations.

Skills

Clinical trial design

Regulatory interactions

Cross-functional collaboration

Education

MD/DO

Neurology board certification (preferred)

Job description

Scorpion Therapeutics is seeking a Medical Director to provide clinical oversight and monitoring for early to mid-phase oncology and autoimmune trials, with a focus on neurology and autoimmune indications, including CAR T therapies. The role involves study design input, regulatory interactions, and cross-functional collaboration.

Candidates should have an MD/DO with 2-5 years in clinical/scientific drug development, GCP knowledge, and the ability to engage investigators.